Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xuanfei jiedu decoction
- Development stage
- Unknown
- Lead developer
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Xuanfei Jiedu Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of respiratory viral infections, specifically COVID-19. Developed by the Shanghai Hospital of Traditional Chinese Medicine, it is designed to ventilate the lungs (Xuanfei) and clear toxins (Jiedu), addressing symptoms such as cough, fever, and lung congestion. In clinical studies, it has been evaluated for its efficacy in children with asymptomatic or mild COVID-19 variant infections, often compared against standard care or interferon nebulization. The formula typically consists of a combination of botanical extracts known for their anti-inflammatory and antiviral properties in TCM practice.
- Other names
- Xuanfei Jiedu FormulaXuanfei Jiedu Fang宣肺解毒方
Beyond the preview
Go deeper on xuanfei jiedu decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xuanfei jiedu decoction.